LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 131 pages found matching Glaxo- What to Expect in Zantac Cancer Lawsuits for 2021 and Beyond
Dec-8-20 West Palm Beach, FL As 2020 draws to a close, the toll of death and injury from Zantac-related cancers continues to rise, as do the number of Zantac cancer lawsuits . Meanwhile, In Re: Zantac (Ranitidine) Products Liability Litigation , the multidistrict litigation into which many of the individual lawsuits have been consolidated, grinds on without muc... - FDA Pulls Zantac off Shelves
Jul-6-20 Washington, DC On April 1, the federal Food and Drug Administration asked manufacturers to withdraw Zantac and all other prescription and over-the-counter ranitidine drugs from the market immediately. It has also advised those who use OTC ranitidine medications to stop taking them immediately and patients with ranitidine prescriptions to speak with their... - Zantac Cancer Lawsuits Move to MDL Phase
Mar-20-20 West Palm Beach, FL Zantac cancer lawsuits will be consolidated in multidistrict litigation in the U.S. District Court for the Southern District of Florida. At the time of its formation on February 6, the MDL included 15 cases. An additional 126 cases were pending in 21 districts nationwide, and more plaintiffs are expected to join. The consolidated la... - New Research: Brief Heat Exposure Increases Zantac Cancer Odds
Jan-14-20 Washington, DC Emery Pharma, a California-based testing laboratory has reported that Zantac appears to produce unacceptably high levels of cancer-causing N-Nitrosodimethylamine (NDMA) when exposed to heat for as little as five days. Brief periods of modestly inadequate temperature control can easily occur during transport, storage or even in consumer&rsq... - Zantac Medication Cancer Legal News & Lawsuit Information
Zantac (ranitidine hydrochloride) is being investigated after 150 Zantac tablets were found to contain a carcinogenic chemical up to 3,000 times greater than the FDA’s daily intake limit. The chemical found in the popular heartburn drug is N-nitrosodimethylamine (“NDMA”). Numerous studies have shown a link between the NDMA in Zantac and can... - Zofran Litigation Making Progress
Sep-12-16 Houston, TX: Another Zofran lawsuit filed by parents in Texas joins more than 300 suits filed nationwide against the manufacturer. Most all federal cases consolidated into a multidistrict litigation in Massachusetts are making progress and a first trial date is expected soon. Zofran Litigation Summary July 2016: Glaxo Smith Kline (GSK) prop... - GlaxoSmithKline Faces Zofran Birth Defect Lawsuits
Mar-30-16 Pittsburgh, PA: GlaxoSmithKline faces more Zofran lawsuits alleging babies developed birth defects after being exposed to Zofran in the womb. While some women say their children have outgrown the Zofran side effects, others say the effects have lasted well into their child's life, and traumatized their families. With lawsuits consolidated for pretrial... - Judge Denies GlaxoSmithKline Motion to Dismiss Lawsuits
Jan-27-16 New York, NY: A judge has reportedly denied GlaxoSmithKline’s motion to dismiss Zofran lawsuits , which alleged the morning sickness drug caused birth defects in infants exposed to the medication prior to birth. Plaintiffs in the Zofran side effects lawsuits argued it’s too early to dismiss the lawsuits because no discovery has happened yet,... - Mother “Channeling Anger into a Zofran Lawsuit”
Sep-7-15 New York, NY At least three dozen lawsuits claim that Zofran used during pregnancy caused children to be born with birth defects. The birth defects range from cleft palate to spina bifida and the most recent - a missing kidney. But every lawsuit is similar in its allegations. And every mother said that, had she known Zofran can cause birth defects, she... - GlaxoSmithKline Fined Again—The Cost of Doing Business?
Jun-26-14 It is seen as the cost of doing business. It may be illegal, but is also highly profitable, so why stop? That seems to be the attitude of many pharmaceutical companies - and the latest proof of this comes in the form of a $105 million fine leveled against GlaxoSmithKline Plc. (GSK). The California Attorney General Kamala Harris announced the fine saying h... - Avandia FAQ
What is Avandia? Avandia (known generically as rosiglitazone maleate) is a drug that was developed to treat type 2 diabetes mellitus. It is manufactured by GlaxoSmithKline and was first approved by the US Food and Drug Administration (FDA) in 1999. Avandia reduces the patient's insulin resistance and helps the patient's body use the insulin it produce... - Avandia - Avandia Lawsuit, Avandia Side Effects - LawyersAndSettlements.com
Avandia (rosiglitazone maleate) is a GlaxoSmithKline (GSK) drug developed to treat type 2 diabetes mellitus. First approved by the FDA in 1999, the agency reported eight years later a significant increase in the risk of heart attack in those patients to whom Avandia had been prescribed. And many deaths have been linked to Avandia. More recently, two... - Glaxo Looking to Advance Rest of OTC Asset Sales As Alli Side Effects Remain
Feb-1-12 London, England GlaxoSmithKline Plc is trying to sell its remaining over-the-counter medicine brands as quickly as possible, due to the ongoing issues with Alli side effects and other medications, according to Bloomberg . The news outlet reported that the company's chief financial officer noted that they are continuing the process of divesting othe... - Pharma "Sales" Representatives Entitled to California Overtime
Jan-26-12 Sacramento, CA The preliminary approval granted to current and former Novartis Pharmaceutical sales representatives to the tune of $99 million likely has Glaxo sales reps and other pharma sales reps optimistic regarding the outcome of their California Overtime lawsuits. On January 25, 2012, Novartis, which is based in New Jersey, agreed to settle th... - Coming Out from the Shadow of Paxil Birth Defects
Dec-13-11 Washington, DC Anyone sitting on the fence over whether or not to go after GlaxoSmithKline (Glaxo) over Paxil side effects need only contemplate the reported $3 billion that Glaxo has agreed in principal to pay, in order to settle charges of off-label marketing and fraud. Combine that figure with the reported $1 billion Glaxo is believed to have pai... - Wellbutrin Side Effects - Wellbutrin Birth Defects, Zyban Side Effects, Wellbutrin Lawsuit
Wellbutrin (known generically as bupropion hydrochloride) is approved to treat patients with major depressive disorder. Wellbutrin side effects may include serious health events, such as Wellbutrin birth defects in infants when taking Wellbutrin while pregnant . Those birth defects include potentially serious congenital heart defects. ... - SSRI Antidepressants causing suicidal behavior
With recommendations from the Psychopharmacologic Drugs Advisory Committee and the Pediatric Drugs Advisory Committee, the Food and Drug Administration (FDA) announced a Public Health Advisory directing antidepressant manufacturers to expand their warning label on October 15, 2004. While the FDA's recommended "Black Box" warning label is extens... - Pharmaceutical Sales Overtime Debate Will Go On
Apr-21-11 Portland, OR Long after the last appeal has been filed and the final arguments made, debate will continue to rage over whether or not individuals performing in pharmaceutical sales are entitled to overtime pay. Pharmaceutical reps promote the products of their employers—which are then prescribed to patients by doctors and dispensed through pharma... - Avandia Settlement Reached in Burford Case
London, UK: GlaxoSmithKline (GSK), has settled an Avandia lawsuit that alleged the diabetes medication caused the death of a North Carolina man. The suit was filed by the family of James Burford who died of a heart attack in 2006 while using the drug. The settlement was arranged the night before GSK was due to go to court over the case, which is t... - Paxil y HPPR
[ IN ENGLISH ] El 27 de septiembre de 2005, la Adminstración de Alimentos y Drogas (FDA) alertó a los profesionales de la salud y a los consumidores respecto de la modificación introducida por GlaxoSmithKline en su aviso de advertencia de Paxil (paroxetina), en el que se incluyó el riesgo de defectos de nacimiento. Los res...